Carfilzomib and dexamethasone vs bortezomib and dexamethasone in patients with relapsed multiple myeloma: results of the phase 3 study ENDEAVOR (NCT01568866) according to age subgroup
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article (Journal) Editorial |
| Language: | English |
| Published: |
17 March 2017
|
| In: |
Leukemia and lymphoma
Year: 2017, Volume: 58, Issue: 10, Pages: 2501-2504 |
| ISSN: | 1029-2403 |
| DOI: | 10.1080/10428194.2017.1298755 |
| Online Access: | Verlag, Volltext: https://doi.org/10.1080/10428194.2017.1298755
|
| Author Notes: | Heinz Ludwig, Meletios A. Dimopoulos, Philippe Moreau, Wee-Joo Chng, Hartmut Goldschmidt, Roman Hájek, Thierry Facon, Ludek Pour, Ruben Niesvizky, Albert Oriol, Laura Rosiñol, Aleksandr Suvorov, Gianluca Gaidano, Tomas Pika, Katja Weisel, Vesselina Goranova-Marinova, Antonio Palumbo, Heidi H. Gillenwater, Nehal Mohamed, Sanjay Aggarwal, Shibao Feng & Douglas Joshua |
| Item Description: | Gesehen am 23.05.2018 |
|---|---|
| Physical Description: | Online Resource |
| ISSN: | 1029-2403 |
| DOI: | 10.1080/10428194.2017.1298755 |